What is the Revvity Inc (RVTY) price today?

The price of Revvity Inc (RVTY) today is $93.96. This value reflects the latest market rate available on Pluang. Check the asset page for additional details such as 24-hour change, market trends, and trading volume.

What are the trading hours of US Stocks?

US stocks trading hours: Monday - Friday (Except for US public holidays) Time: 21.30 - 04.00 WIB 20.30 - 03.00 WIB (Daylight Savings Time*) *The next Daylight Savings is scheduled to begin on March 13, 2022 and ends on November 6, 2022. You can place limit orders outside of the trading hours, but it can only be executed during trading hours. For illustration, a stock is currently trading at $10 per share, but you only want to pay $7 per share at most. Let’s say you set your limit price to $7 at 18.00. Your order will be executed when the market is open at 21.30 if the stock drops from $10 to $7 or lower. Similarly, if the stock price doesn’t drop to $7, your order won’t be executed.

Do I get a dividend from investing in US Stocks?

Yes, you are eligible to receive dividend payment if and when the company pays them on one condition: minimum net dividend paid is at least $0.01. Net dividend is gross dividend subtracted by 15% withholding tax.

What is the fee for each transaction?

Pluang charges a fixed transaction fee of 0.30% for regular users and 0.20% for Pluang Plus members, including VAT to cover the exchange fees and operational costs.

Trade on Pluang

One platform for all markets

Download

Investment

Features

Fees Safety

Academy

Pluang+

Home/Explore/US Market Price/Stocks/RVTY

Buy & Sell Revvity Inc (RVTY) – Revvity Inc Price Today

Overview Financials Technicals Analysis Corp Action About

24H

YTD

Aura AI Summary

RVTY trades at $93.96, up 4.95% today, with strong earnings momentum after beating EPS estimates for three consecutive quarters. The stock shows positive technical momentum near its 52-week high, supported by a consensus analyst price target of $106. Recent product launches like Signals BioDesign and upcoming investor conferences highlight ongoing business development. Valuation metrics include a P/E of 43.46 and P/S of 3.65, reflecting premium pricing relative to sector averages.

The outlook remains favorable given consistent earnings beats and analyst bullishness, though elevated valuation and China-related headwinds pose risks. Revenue growth of 5.9% in Q4 2025 and robust diagnostic segment performance underpin the positive sentiment, while margin pressures and soft research spending require monitoring for sustained upside.

Read full analysis

Key Stats

Market Cap
$10.51B
Sector
Technology
3M Drawdown
-28.75%
Enterprise Value
$12.98B
Dividend Yield
0.3%

$93.96

52W Low: $82.5

10 Sep 2025

52W High: $117.75

22 Jan 2026

Revvity Inc (RVTY) is currently valued at a market capitalization of $10.51B, with an enterprise value of $12.98B. Over the past 52 weeks, Revvity Inc has traded between a low of $82.5 and a high of $117.75, highlighting its annual price range. Over the past three months, Revvity Inc has recorded a drawdown of -28.75%, reflecting recent price volatility. Revvity Inc offers a dividend yield of 0.3%, with the most recent dividend of $0.07 paid on 17 Apr 26.

About Revvity Inc

Revvity, Inc., formerly the Life Sciences and Diagnostics businesses of PerkinElmer, is a global provider of scientific and diagnostic solutions. The company focuses on the health and wellness of humanity through its expertise in life science research, detection, imaging, and informatics. Revvity supplies a broad portfolio of instruments, reagents, and services to pharmaceutical companies, academic research institutions, and clinical laboratories worldwide, enabling customers to make advancements in human health.

Technical Indicators

Overall Summary

Bearish (6)Neutral (2)Bullish (15)

News

The Motley Fool9 mon ago

Revvity Q2 Revenue Up 4 Percent

Globe Newswire9 mon ago

CRISPR Gene Editing Market Surges USD 4.77 in 2025, `Vertex’s Casgevy, AI-Powered OpenCRISPR-1 and Trisomy 21 Breakthrough Fuels Growth

Globe Newswire1 year ago

Global Preeclampsia Diagnostics Market to Exhibit Growth at a CAGR of ~4% by 2032 | DelveInsight

Globe Newswire1 year ago

High Content Screening and Imaging Market Set for 8.4% CAGR Through 2029

Globe Newswire1 year ago

Neurogenomics Market Forecast and Trends Analysis to 2031: Healthcare Investments and Early Detection Drive Robust Uptake of Neurogenomics Solutions

People also bought

US Stocks risk is managed by PT PG Berjangka which has a license from the Badan Pengawas Perdagangan Berjangka Komoditi (BAPPEBTI), and your investment is guaranteed by the Jakarta Futures Exchange (JFX) and the Indonesian Clearing House (KBI). Read our product’s Terms and Conditions. View Terms and Conditions

Key Stats

Market Cap
$10.51B
Sector
Technology
3M Drawdown
-28.75%
Enterprise Value
$12.98B
Dividend Yield
0.3%

$93.96

52W Low: $82.5

10 Sep 2025

52W High: $117.75

22 Jan 2026

Let’s invest in this asset by signing up or download!

Buy & Sell Revvity Inc (RVTY) – Revvity Inc Price Today

Aura AI Summary

Key Stats

About Revvity Inc

People also bought

Key Stats

Invest

Features

Fees

Learn

Investment Clubs (Coming Soon)

Support

iOS App Store

Google Play Store